Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholding for the Period Ended December 31, 2019
Aspira Pathlab & Diagnostics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we are forwarding herewith a copy of the certificate dated January 01, 2020, received from M/S. Sharex Dynamic (India) Pvt. Ltd. the Registrar and Transfer Agent of the Company, for the quarter ended December 31, 2019. We request you to kindly take above on the records. Aspira Pathlab & Diagnostics Ltd - 540788 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mamta MavDesignation :- Company Secretary and Compliance Officer Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window
The financial results of the Company for the quarter ending December 31, 2019 will be declared in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. With reference to the above captioned matter, we would like to inform you that pursuant to the Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct for prohibition of insider trading ('Code') the trading window for dealing in securities of the Company will be closed for the purpose of declaration of Un-audited Financial Results of the Company for the quarter ended December 31, 2019 for all the Designated person of the Company from Wednesday, January 01, 2020 and shall open 48 hours after announcement of the financial Results, for all its designated persons. Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholding for the Period Ended November 27, 2019
Aspira Pathlab & Diagnostics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended November 27, 2019. For more details, kindly Click here Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholding for the Period Ended November 22, 2019
Aspira Pathlab & Diagnostics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended November 22, 2019. For more details, kindly Click here Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vincent Commercial Company Ltd Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Glorious Holdings Pvt Ltd Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligation &Disclosure; Requirements) Regulations, 2015 For The Half Year Ended September 30,2019
Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligation &Disclosure; Requirements) Regulations, 2015, we hereby submit the disclosure on Related Party Transactions, on standalone basis, drawn in accordance with applicable accounting standards for the half-year ended September 30, 2019. Kindly take the above information on record and acknowledge the receipt. Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Yashraj Biotechnology Ltd & Others